Reta 30mg
Tap to choose an option
This product is sold exclusively for laboratory research purposes. Please ensure you are a qualified researcher before proceeding with purchase.
Retatrutide is a next-generation weight and metabolic peptide often called a "triple agonist" because it hits three pathways at once — GLP-1, GIP, and glucagon. Most weight-loss peptides only hit one or two. GLP-1 and GIP help control appetite, blood sugar, and insulin response — the same pathways behind Ozempic and Tirzepatide. The glucagon piece is what sets Reta apart: it's studied for its ability to increase energy burn and reduce fat, which is why research shows bigger changes in body composition than with dual-agonist peptides. Studied for weight, blood sugar, blood pressure, and metabolic health endpoints. Sold as a research reference standard for in-vitro laboratory use only. Not a drug, dietary supplement, food, cosmetic, or medical device. Not for human or veterinary use, and not intended to diagnose, treat, cure, or prevent any condition.
Research notes
- •Triple GIP / GLP-1 / glucagon receptor agonism
- •Investigated for body weight and glycemic endpoints
- •Studied for effects on hepatic fat and blood pressure
For research use only. Not for human or veterinary use. This product must be handled by trained personnel in accordance with institutional biosafety guidelines.
You may also research
What buyers say about Reta 30mg
"Purity is exactly what the COA says. Reconstitutes clean, no cloudiness, no floaties. Best sourcing I've had in three years of research."